Home › Companies › Bio-Rad Laboratories, Inc. › 2024-2025

Bio-Rad Laboratories, Inc. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and Bio-Rad Laboratories, Inc.’s Form 8-K, filed April 25, 2025 (Item 5.07 on EDGAR). Page generated October 14, 2026.

  • 10Reported items
  • 130Asset managers
  • 1,646Fund votes
  • April 22, 2025Meeting date

Results at a glance

Meeting of April 22, 2025: 6 items on Bio-Rad Laboratories, Inc.’s Form 8-K, filed April 25, 2025: 6 without a stated outcome.

Material dissent

None.

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore Bio-Rad Laboratories, Inc. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by Bio-Rad Laboratories, Inc.

These tallies are Bio-Rad Laboratories, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed April 25, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Bio-Rad Laboratories, Inc. — official shareholder meeting results, meeting held April 22, 2025
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Melinda Litherland 16,693,5883,918,47810,596 --1,195,004 81%Not verified—
Elect Director: Arnold A. Pinkston 17,013,7653,598,33110,566 --1,195,004 83%Not verified—
Elect Director: Jeffrey L. Edwards 4,989,57734191 --33,701 99.9%Not verified—
Elect Director: Gregory K. Hinckley 4,989,57734191 --33,701 99.9%Not verified—
Elect Director: Allison Schwartz 4,988,4651,45391 --33,701 99.9%Not verified—
Elect Director: Norman Schwartz 4,988,4651,45391 --33,701 99.9%Not verified—

Source: Bio-Rad Laboratories, Inc., Form 8-K, filed with the SEC on April 25, 2025 — read the filing on EDGAR.

How asset managers voted at the Bio-Rad Laboratories, Inc. 2024-2025 meeting

Each item below shows how the 130 asset managers that disclosed a Bio-Rad Laboratories, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Bio-Rad Laboratories, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Elect Director: Arnold A. Pinkston

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 5 wordings of this item as funds reported it.

83% Majority: yes · of votes cast

FOR 83%AGAINST
FOR: 17,013,765AGAINST: 3,598,331
Details: description as filed, official tally, votes by 121 asset managers

Description as filed by funds: Nominees: Arnold A. Pinkston

Bio-Rad Laboratories, Inc.’s own tally for this item (“Elect Director: Arnold A. Pinkston”): 17,013,765 for, 3,598,331 against, per its Form 8-K filed April 25, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 83% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 121 asset managers below reported 6,700,358 for, 1,972,796 against, 3,601 abstained.

FORAGAINST
FOR: 6,700,358AGAINST: 1,972,796ABSTAIN: 3,601
Largest asset managers voting on “Nominees: Arnold A. Pinkston” at Bio-Rad Laboratories, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard1,909,2380 00For
VanEck ETF Trust01,134,115 00Against
FIRST EAGLE FUNDS1,052,8560 00For
BlackRock873,4080 00For
Dimensional656,4150 00For
ARIEL INVESTMENT TRUST353,1430 00For
Fidelity308,32012,353 00For
Parnassus0318,111 00Against
LONGLEAF PARTNERS FUNDS TRUST202,8960 00For
Charles Schwab0195,069 00Against
Investment Managers Series Trust III157,1180 00For
State Street1,968127,498 00Against
Jackson National128,4410 00For
Allspring121,1230 00For
John Hancock111,3570 00For
Transamerica104,3770 00For
HARBOR FUNDS70,1530 00For
Putnam059,707 00Against
Equitable27,99022,878 00Mixed
Artisan48,0180 00For
TRUST FOR PROFESSIONAL MANAGERS43,0820 00For
FRANKLIN VALUE INVESTORS TRUST041,406 00Against
Gabelli40,3000 00For
Brighthouse34,7730 3,6010Mixed
TIAA37,9820 00For

Showing the 25 largest of 121 asset managers. See all 121 in the interactive database.

2. Elect Director: Melinda Litherland

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 5 wordings of this item as funds reported it.

81% Majority: yes · of votes cast

FOR 81%AGAINST
FOR: 16,693,588AGAINST: 3,918,478
Details: description as filed, official tally, votes by 121 asset managers

Description as filed by funds: Nominees: Melinda Litherland

Bio-Rad Laboratories, Inc.’s own tally for this item (“Elect Director: Melinda Litherland”): 16,693,588 for, 3,918,478 against, per its Form 8-K filed April 25, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 81% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 121 asset managers below reported 6,431,397 for, 2,241,757 against, 3,601 abstained.

FORAGAINST
FOR: 6,431,397AGAINST: 2,241,757ABSTAIN: 3,601
Largest asset managers voting on “Nominees: Melinda Litherland” at Bio-Rad Laboratories, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard1,909,2380 00For
VanEck ETF Trust01,134,115 00Against
FIRST EAGLE FUNDS1,052,8560 00For
BlackRock873,4080 00For
Dimensional656,4150 00For
ARIEL INVESTMENT TRUST353,1430 00For
Fidelity39,359281,314 00Mixed
Parnassus0318,111 00Against
LONGLEAF PARTNERS FUNDS TRUST202,8960 00For
Charles Schwab0195,069 00Against
Investment Managers Series Trust III157,1180 00For
State Street1,968127,498 00Against
Jackson National128,4410 00For
Allspring121,1230 00For
John Hancock111,3570 00For
Transamerica104,3770 00For
HARBOR FUNDS70,1530 00For
Putnam059,707 00Against
Equitable27,99022,878 00Mixed
Artisan48,0180 00For
TRUST FOR PROFESSIONAL MANAGERS43,0820 00For
FRANKLIN VALUE INVESTORS TRUST041,406 00Against
Gabelli40,3000 00For
Brighthouse34,7730 3,6010Mixed
TIAA37,9820 00For

Showing the 25 largest of 121 asset managers. See all 121 in the interactive database.

3. Election of Directors (Majority Voting)

No official matchDIRECTOR ELECTIONS

All nominees (reported as one line). These filers reported the election of directors as a single line covering every nominee. It is not attributed to any one director, and no share total is shown for it.

100% of fund votes cast · no official result

FOR
Details: votes by 2 asset managers

The 2 asset managers below reported this as one line covering every nominee; it is not attributed to any one director, and no share total is shown for it.

Largest asset managers voting on “Election of Directors (Majority Voting)” at Bio-Rad Laboratories, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
WILLIAMSBURG INVESTMENT TRUST1,0000 00For
Simplify Exchange Traded Funds80 00For

4. Proposal to ratify the selection of KPMG LLP to serve as the Company's independent auditors.

No official matchAUDIT-RELATED

Combines 2 wordings of this item as funds reported it.

99.9% of fund votes cast · no official result

FOR
Details: votes by 116 asset managers

The 116 asset managers below reported 8,651,263 for, 6 against, 3,601 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 8,651,263AGAINST: 6ABSTAIN: 3,601
Largest asset managers voting on “Proposal to ratify the selection of KPMG LLP to serve as the Company's independent auditors.” at Bio-Rad Laboratories, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard1,909,2380 00For
VanEck ETF Trust1,134,1150 00For
FIRST EAGLE FUNDS1,052,8560 00For
BlackRock873,4080 00For
Dimensional656,4150 00For
ARIEL INVESTMENT TRUST353,1430 00For
Fidelity320,6730 00For
Parnassus318,1110 00For
LONGLEAF PARTNERS FUNDS TRUST202,8960 00For
Charles Schwab195,0690 00For
Investment Managers Series Trust III157,1180 00For
State Street129,4606 00For
Jackson National128,4410 00For
Allspring121,1230 00For
John Hancock111,3570 00For
Transamerica104,3770 00For
HARBOR FUNDS70,1530 00For
Putnam59,7070 00For
Equitable50,8680 00For
Artisan48,0180 00For
TRUST FOR PROFESSIONAL MANAGERS43,0820 00For
FRANKLIN VALUE INVESTORS TRUST41,4060 00For
Gabelli40,4500 00For
Brighthouse34,7730 3,6010Mixed
TIAA37,9820 00For

Showing the 25 largest of 116 asset managers. See all 116 in the interactive database.

5. Ratify KPMG LLP as Auditors

No official matchAUDIT-RELATED

100% of fund votes cast · no official result

FOR
Details: votes by 5 asset managers

The 5 asset managers below reported 19,822 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 19,822
Largest asset managers voting on “Ratify KPMG LLP as Auditors” at Bio-Rad Laboratories, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Empower10,6400 00For
GreenFi Funds Trust8,2450 00For
HC CAPITAL TRUST3980 00For
CLEARWATER INVESTMENT TRUST3000 00For
GuideStone2390 00For

6. Ratify Appointment of Independent Auditors

100% Fund and manager reports combined; may count the same shares twice · no official result

FOR
Details: votes by 3 asset managers

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 2 asset managers voting on “Ratify Appointment of Independent Auditors” at Bio-Rad Laboratories, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
WILLIAMSBURG INVESTMENT TRUST1,0000 00For
Simplify Exchange Traded Funds80 00For

Fund voting reports, all 2 managers: 1,008 for.

Institutional-manager reports: 1 asset manager voting on “Ratify Appointment of Independent Auditors” at Bio-Rad Laboratories, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Cardano Risk Management B.V.2,2130 00For

Institutional-manager reports, all 1 managers: 2,213 for.

7. Stockholder proposal requesting approval of certain executive severance arrangements.

No official matchCOMPENSATION

Combines 3 wordings of this item as funds reported it.

41% of fund votes cast · no official result

FORAGAINST
Details: votes by 119 asset managers

The 119 asset managers below reported 3,582,721 for, 5,082,272 against, 3,601 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 3,582,721AGAINST: 5,082,272ABSTAIN: 3,601
Largest asset managers voting on “Stockholder proposal requesting approval of certain executive severance arrangements.” at Bio-Rad Laboratories, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard01,909,238 00Against
VanEck ETF Trust1,134,1150 00For
FIRST EAGLE FUNDS3,4731,049,383 00Against
BlackRock0873,408 00Against
Dimensional656,4150 00For
ARIEL INVESTMENT TRUST0353,143 00Against
Fidelity306,58914,084 00For
Parnassus318,1110 00For
LONGLEAF PARTNERS FUNDS TRUST0202,896 00Against
Charles Schwab0195,069 00Against
Investment Managers Series Trust III157,1180 00For
State Street1,955127,511 00Against
Jackson National4,954123,487 00Against
Allspring121,1230 00For
John Hancock111,3570 00For
Transamerica104,3770 00For
HARBOR FUNDS70,1530 00For
Putnam59,7070 00For
Equitable22,87827,990 00Mixed
Artisan48,0180 00For
TRUST FOR PROFESSIONAL MANAGERS42,752330 00For
FRANKLIN VALUE INVESTORS TRUST41,4060 00For
Gabelli040,450 00Against
Brighthouse34,7730 3,6010Mixed
TIAA37,9820 00For

Showing the 25 largest of 119 asset managers. See all 119 in the interactive database.

8. Submit Severance Agreement to Shareholder Vote

No official matchFund totals may overlapSECTION 14A SAY-ON-PAY VOTES

18% Fund and manager reports combined; may count the same shares twice · no official result

FORAGAINST
Details: votes by 8 asset managers

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 5 asset managers voting on “Submit Severance Agreement to Shareholder Vote” at Bio-Rad Laboratories, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Empower9,951689 00Mixed
GreenFi Funds Trust08,245 00Against
HC CAPITAL TRUST3980 00For
CLEARWATER INVESTMENT TRUST3000 00For
GuideStone2390 00For

Fund voting reports, all 5 managers: 10,888 for, 8,934 against.

Institutional-manager reports: 3 asset managers voting on “Submit Severance Agreement to Shareholder Vote” at Bio-Rad Laboratories, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
SOUTHEASTERN ASSET MANAGEMENT INC/TN/0249,849 00Against
Bellevue Group AG34,9070 00For
Hosking Partners LLP12,5580 00For

Institutional-manager reports, all 3 managers: 47,465 for, 249,849 against.

9. S/H Proposal - Corporate Governance

No official matchINVESTMENT COMPANY MATTERS

100% of fund votes cast · no official result

FOR
Details: votes by 2 asset managers

The 2 asset managers below reported 18,008 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 18,008
Largest asset managers voting on “S/H Proposal - Corporate Governance” at Bio-Rad Laboratories, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
WILLIAMSBURG INVESTMENT TRUST18,0000 00For
Simplify Exchange Traded Funds80 00For

10. Shareholder Proposal Regarding Severance Approval Policy

No official matchCOMPENSATION

100% of fund votes cast · no official result

FOR
Details: votes by 2 asset managers

The 2 asset managers below reported 2,283 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 2,283
Largest asset managers voting on “Shareholder Proposal Regarding Severance Approval Policy” at Bio-Rad Laboratories, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Cardano Risk Management B.V.2,2130 00For
OSSIAM700 00For

Largest Bio-Rad Laboratories, Inc. shareholders voting in 2024-2025

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 27,941,000 shares outstanding at the time of that meeting.

Fund voting reports: top Bio-Rad Laboratories, Inc. shareholders by shares voted on “Nominees: Arnold A. Pinkston”, 2024-2025
#Asset manager % of shares outstanding
1Vanguard 6.83%
2VanEck ETF Trust 4.06%
3FIRST EAGLE FUNDS 3.77%
4BlackRock 3.13%
5Dimensional 2.35%
6ARIEL INVESTMENT TRUST 1.26%
7Fidelity 1.15%
8Parnassus 1.14%
9LONGLEAF PARTNERS FUNDS TRUST 0.73%
10Charles Schwab 0.70%
Institutional-manager reports: top Bio-Rad Laboratories, Inc. shareholders by shares voted on “Stockholder proposal requesting approval of certain executive severance arrangements.”, 2024-2025
#Asset manager % of shares outstanding
1AYAL Capital Advisors Ltd 0.05%
2MITCHELL & PAHL PRIVATE WEALTH, LLC <0.01%
3Fortitude Family Office, LLC <0.01%

Reported Bio-Rad Laboratories, Inc. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

Bio-Rad Laboratories, Inc. holdings and ownership disclosed for the 2024-2025 proxy season
Holder % outstanding Disclosure
Norman D. Schwartz 11.56% 13D
BIO-RAD LABORATORIES, INC 9.89% 13G
Alice N. Schwartz 9.78% 13D
BlackRock 7.24% 13F
Vanguard Group 6.84% 13F
Dimensional Fund Advisors 3.14% 13F
State Street 2.49% 13F
Geode Capital 1.23% 13F
Millennium Management 1.20% 13F
Northern Trust 0.93% 13F

Percentages above are of 27,941,000 shares outstanding, as reported by Bio-Rad Laboratories, Inc. on its Form 10-Q dated March 31, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Bio-Rad Laboratories, Inc.’s 10-Q dated March 31, 2025. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.

At Bio-Rad Laboratories, Inc.'s shareholder meeting held April 22, 2025, in the 2024-2025 proxy season, 130 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,646 separate fund positions. Their filings are grouped here into 10 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Nominees: Arnold A. Pinkston — FOR was 83% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: Bio-Rad Laboratories, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on April 25, 2025.

Bio-Rad Laboratories, Inc. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.

Download data (CSV): ballot items · votes by manager · column guide.